The Columbia University Bioethics program is pleased to invite you to a series of free, online webinars examining critical ethical and policy issues that arise in the context of drug and device development and the pharmaceutical industry. Our first webinar will focus on ethical questions posed by Direct-to-Consumer (DTC) pharmaceutical advertising.
The United States and New Zealand are the only countries that allow DTC pharmaceutical advertising. Supporters of DTC advertising argue that it represents free speech and informs patients about possible treatments while others argue that limits should be imposed. Dr. Robert Klitzman will moderate a discussion on these timely and important ethical questions regarding DTC advertising with an extraordinary panel of distinguished speakers.
For further information, please contact Lillian Ringel at [email protected] or visit the website.
